MedTrace Logo

Comparative Performance of PureVision, Acuvue Oasys and O2Optix

NCT00640341 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 510

Last updated 2011-12-12

Study results available
· View outcomes & findings →

Summary

The objective of this study is to evaluate the performance of the PureVision Contact Lens compared to Acuvue Oasys Contact lens and O2Optix Contact lens when worn on a daily wear basis.

Conditions

  • Myopia

Interventions

DEVICE

PureVision Contact Lens

contact lens for daily wear

DEVICE

Acuvue Oasys Contact Lens

contact lens for daily wear

DEVICE

O2Optix Contact lens

contact lens for daily wear

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Gerard Cairns, MCOptom, PhD · Bausch & Lomb Incorporated

  • Bruce Anderson, OD · Anderson & Associates

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2008-04-30
Completion
2008-04-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00640341 on ClinicalTrials.gov